• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估精神分裂症的阴性症状和抑郁:SANS 的修订以及它与 PANSS 和 CDSS 的关系。

Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.

机构信息

The Emotion-Cognition Research Center, Shalvata Mental Health Center, Hod-Hasharon, Israel.

出版信息

Schizophr Res. 2011 Mar;126(1-3):226-30. doi: 10.1016/j.schres.2010.09.023. Epub 2010 Nov 5.

DOI:10.1016/j.schres.2010.09.023
PMID:21115328
Abstract

OBJECTIVE

The Scale for the Assessment of Negative Symptoms (SANS) is the most widely used instrument for measuring negative symptoms in schizophrenia. The validity of its factor structure has not been established. Congruence of the SANS and its subscales to the negative subscale of the Positive and Negative Symptom Scale (PANSS-N) and the Calgary Depression Scale for Schizophrenia (CDSS) were never explored. The current study revised SANS's structure and examined its correlations with the PANSS and the CDSS.

METHOD

Two-hundred and forty patients with schizophrenia with predominantly negative symptoms were analyzed. A principal component analysis was conducted for SANS. Spearman's correlations were conducted for SANS and PANSS-N, and for SANS and CDSS.

RESULTS

Principal Component Analyses (PCA) of SANS revealed four factors, corresponding to the original SANS subscales with two exceptions: Item #13 (grooming and hygiene) loaded on the alogia factor rather than on its original affective flattening factor, and Item #4 (poor eye contact) did not load onto any factor. The total PANSS-N score showed a moderate correlation with the SANS and all of its subscales. The total CDSS score showed a low negative correlation with the total SANS score and with its avolition subscale.

CONCLUSIONS

Our results supported the validity of SANS's structure except for "poor eye contact" and "grooming end hygiene". The moderate correlation between SANS and PANSS-N suggests that although they are not identical, they measure similar constructs. The low negative correlation between SANS and CDSS suggests that they measure different constructs.

摘要

目的

《负性症状评定量表》(SANS)是目前最常用于评估精神分裂症患者阴性症状的工具。其因子结构的有效性尚未得到证实。SANS 及其子量表与阳性和阴性症状量表(PANSS-N)的阴性子量表和精神分裂症卡尔加里抑郁量表(CDSS)之间的一致性从未被探索过。本研究对 SANS 的结构进行了修订,并考察了其与 PANSS 和 CDSS 的相关性。

方法

对 240 名以阴性症状为主的精神分裂症患者进行分析。对 SANS 进行主成分分析。对 SANS 与 PANSS-N 及 SANS 与 CDSS 进行 Spearman 相关分析。

结果

SANS 的主成分分析(PCA)显示有四个因子,与 SANS 的原有子量表相对应,但有两个例外:项目 13(修饰和卫生)在言语贫乏因子上而不是在其原有的情感迟钝因子上,项目 4(眼神接触不佳)未加载到任何因子上。PANSS-N 的总分与 SANS 及其所有子量表均呈中度相关。CDSS 的总分与 SANS 的总分及失活子量表呈低度负相关。

结论

除了“眼神接触不佳”和“修饰和卫生”之外,我们的结果支持 SANS 结构的有效性。SANS 与 PANSS-N 之间的中度相关性表明,尽管它们不完全相同,但它们测量的是相似的结构。SANS 与 CDSS 之间的低度负相关性表明,它们测量的是不同的结构。

相似文献

1
Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.评估精神分裂症的阴性症状和抑郁:SANS 的修订以及它与 PANSS 和 CDSS 的关系。
Schizophr Res. 2011 Mar;126(1-3):226-30. doi: 10.1016/j.schres.2010.09.023. Epub 2010 Nov 5.
2
Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.评估精神分裂症的阴性症状:新加坡阴性症状临床评估访谈的有效性。
Schizophr Res. 2019 Apr;206:177-182. doi: 10.1016/j.schres.2018.11.029. Epub 2018 Dec 14.
3
Choosing negative symptom instruments: issues of representation and redundancy.选择阴性症状评估工具:代表性和冗余性问题。
Psychiatry Res. 1999 Jul 30;87(1):47-56. doi: 10.1016/s0165-1781(99)00042-6.
4
Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.评估精神分裂症中抑郁的量表:卡尔加里抑郁评定量表和汉密尔顿抑郁评定量表的因子分析。
Psychiatry Res. 2017 Jun;252:333-339. doi: 10.1016/j.psychres.2017.03.018. Epub 2017 Mar 9.
5
Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.从阳性和阴性症状量表(PANSS)主成分分析中提取的抑郁维度在未服用药物的精神分裂症患者中的效度。
Schizophr Res. 2002 Jul 1;56(1-2):121-7. doi: 10.1016/s0920-9964(01)00247-x.
6
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).《精神分裂症卡尔加里抑郁量表(CDSS-P)》的波斯语版本。
Asian J Psychiatr. 2019 Oct;45:44-49. doi: 10.1016/j.ajp.2019.08.017. Epub 2019 Aug 30.
7
Guilt and depression: two different factors in individuals with negative symptoms of schizophrenia.内疚和抑郁:精神分裂症阴性症状个体中的两个不同因素。
Eur Psychiatry. 2013 Aug;28(6):327-31. doi: 10.1016/j.eurpsy.2012.02.008. Epub 2012 Sep 27.
8
Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.精神分裂症患者抑郁与认知洞察力和社会职业结局的关系。
Int J Soc Psychiatry. 2017 May;63(3):181-194. doi: 10.1177/0020764017691314. Epub 2017 Feb 5.
9
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.评估精神分裂症中的抑郁症状: Calgary 精神分裂症抑郁量表与汉密尔顿抑郁评定量表的心理计量学比较。
Psychopathology. 2012;45(5):276-85. doi: 10.1159/000336729. Epub 2012 Jul 12.
10
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).精神分裂症患者卡尔加里抑郁量表(CDSS)的同时效度研究。
J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0.

引用本文的文献

1
Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers.经皮耳迷走神经刺激治疗以阴性症状为主的难治性精神分裂症患者的疗效与安全性:一项随机临床试验及疗效敏感性生物标志物研究
Mol Psychiatry. 2025 Aug 26. doi: 10.1038/s41380-025-03132-8.
2
French Validation of the Brief Negative Symptom Scale (BNSS).简明阴性症状量表(BNSS)的法语版验证
Can J Psychiatry. 2025 Apr;70(4):312-319. doi: 10.1177/07067437251328350. Epub 2025 Mar 21.
3
Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties.
临床医生报告的阴性症状量表:测量属性的系统评价
Schizophr Bull. 2024 Dec 20;51(1):3-16. doi: 10.1093/schbul/sbae168.
4
Correlation of Health-Related Quality of Life with Negative Symptoms Assessed with the Self-Evaluation of Negative Symptoms Scale (SNS) and Cognitive Deficits in Schizophrenia: A Cross-Sectional Study in Routine Psychiatric Care.精神分裂症患者健康相关生活质量与采用阴性症状自评量表(SNS)评估的阴性症状及认知缺陷的相关性:一项常规精神科护理中的横断面研究
J Clin Med. 2023 Jan 23;12(3):901. doi: 10.3390/jcm12030901.
5
FACTORS ASSOCIATED WITH DEPRESSION IN PATIENTS WITH SCHIZOPHRENIA.与精神分裂症患者抑郁相关的因素。
Acta Clin Croat. 2020 Dec;59(4):605-614. doi: 10.20471/acc.2020.59.04.06.
6
EPA guidance on assessment of negative symptoms in schizophrenia.美国环保署关于精神分裂症阴性症状评估的指南。
Eur Psychiatry. 2021 Feb 18;64(1):e23. doi: 10.1192/j.eurpsy.2021.11.
7
Impact of exergames on psychiatric symptoms in older adults with serious mental illness.电子游戏对老年重性精神病患者精神症状的影响。
Aging Ment Health. 2021 Dec;25(12):2229-2234. doi: 10.1080/13607863.2020.1832442. Epub 2020 Oct 21.
8
The safety and efficacy of adjunctive 20-Hz repetitive transcranial magnetic stimulation for treatment of negative symptoms in patients with schizophrenia: A double-blinded, randomized, sham-controlled study.辅助性20赫兹重复经颅磁刺激治疗精神分裂症患者阴性症状的安全性和有效性:一项双盲、随机、假对照研究。
Indian J Psychiatry. 2020 Jan-Feb;62(1):21-29. doi: 10.4103/psychiatry.IndianJPsychiatry_361_19. Epub 2020 Jan 3.
9
Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial.经颅直流电刺激治疗精神分裂症阴性症状的疗效和安全性:一项随机临床试验。
JAMA Psychiatry. 2020 Feb 1;77(2):121-129. doi: 10.1001/jamapsychiatry.2019.3199.
10
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.对精神分裂症阴性症状量表的积极看法:在 SANS、NSA 和 SDS 之间转换分数。
Schizophr Res. 2018 Nov;201:113-119. doi: 10.1016/j.schres.2018.06.014. Epub 2018 Jun 20.